Authors:
SAUSSY DL
GOETZ AS
QUEEN KL
KING HK
LUTZ MW
RIMELE TJ
Citation: Dl. Saussy et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF BUSPIRONE ANALOGS AT ALPHA-1-ADRENOCEPTORS - FURTHER EVIDENCE THAT RAT AORTA ALPHA-1-ADRENOCEPTORS ARE OF THE ALPHA-1D-SUBTYPE, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 136-144
Authors:
AQUINO CJ
ARMOUR DR
BERMAN JM
BIRKEMO LS
CARR RAE
CROOM DK
DEZUBE M
DOUGHERTY RW
ERVIN GN
GRIZZLE MK
HEAD JE
HIRST GC
JAMES MK
JOHNSON MF
MILLER LJ
QUEEN KL
RIMELE TJ
SMITH DN
SUGG EE
Citation: Cj. Aquino et al., DISCOVERY OF 1,5-BENZODIAZEPINES WITH PERIPHERAL CHOLECYSTOKININ (CCK-A) RECEPTOR AGONIST ACTIVITY .1. OPTIMIZATION OF THE AGONIST TRIGGER, Journal of medicinal chemistry, 39(2), 1996, pp. 562-569
Authors:
PATEL MJ
WYPIJ DM
ROSE DA
RIMELE TJ
WISEMAN JS
Citation: Mj. Patel et al., SECRETION OF CYCLIC-GMP BY CULTURED EPITHELIAL AND FIBROBLAST CELL-LINES IN RESPONSE TO NITRIC-OXIDE, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 16-25
Authors:
DEZUBE M
SUGG EE
BIRKEMO LS
CROOM DK
DOUGHERTY RW
ERVIN GN
GRIZZLE MK
JAMES MK
JOHNSON MF
MOSHER JT
QUEEN KL
RIMELE TJ
SAULS HR
TRIANTAFILLOU JA
Citation: M. Dezube et al., MODIFICATION OF RECEPTOR SELECTIVITY AND FUNCTIONAL-ACTIVITY IN CHOLECYSTOKININ PEPTOID LIGANDS, Journal of medicinal chemistry, 38(17), 1995, pp. 3384-3390
Authors:
SUGG EE
KIMERY MJ
DING JM
KENAKIN DC
MILLER LJ
QUEEN KL
RIMELE TJ
Citation: Ee. Sugg et al., CCK-A RECEPTOR-SELECTIVE ANTAGONISTS DERIVED FROM THE CCK-A RECEPTOR-SELECTIVE TETRAPEPTIDE AGONIST BOC-TRP-LYS(TAC)-ASP-MEPHE-NH2(A-71623), Journal of medicinal chemistry, 38(1), 1995, pp. 207-211
Authors:
GOETZ AS
KING HK
WARD SDC
TRUE TA
RIMELE TJ
SAUSSY DL
Citation: As. Goetz et al., BMY-7378 IS A SELECTIVE ANTAGONIST OF THE D-SUBTYPE OF ALPHA(1)-ADRENOCEPTORS, European journal of pharmacology, 272(2-3), 1995, pp. 5-6
Citation: As. Goetz et al., CHARACTERIZATION OF ALPHA-1-ADRENOCEPTOR SUBTYPES IN HUMAN AND CANINEPROSTATE MEMBRANES, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1228-1233